Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
about
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designsAccess to Addiction Pharmacotherapy in Private Health Plans.Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia.Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline.Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Guidelines for the Pharmacotherapy of Schizophrenia in Adults.Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients.Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
P2860
Q28085407-008E7170-CED2-4600-9034-B782324B8AB3Q36025907-10754CC0-C142-440B-BD6F-B0FDD0CC1C8AQ36798150-F5B368E2-9767-4736-B9E2-37C9420238E3Q38578316-C17E5E49-B72E-4CE1-89F0-45CDF219C2F8Q38625817-59359AC9-49C1-4A1F-8137-D52BEAD197ABQ38659006-9434AA1C-CB9C-466C-93A5-3684E23A30B0Q38851847-6376ECE7-D34B-454F-873D-C4E92DBECC28Q39432209-983689E3-2859-4B22-BD3D-041F79AAC1B7Q41656775-6AD423AD-6C67-4726-94E8-759159107F11Q42088414-27A07D41-016B-4677-9CCB-B64A064DFFE4Q50598854-4E27D294-54B8-4189-B42F-4EB4406E1B8AQ58749200-EAAE8528-EBA6-44FD-90D8-7F20516CF414
P2860
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@ast
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@en
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@nl
type
label
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@ast
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@en
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@nl
prefLabel
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@ast
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@en
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@nl
P2093
P2860
P50
P356
P1476
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study
@en
P2093
Alan J Mendelowitz
Alexander Kopelowicz
Daniel R Wilson
Donna Ames
Joanne B Severe
John Hsiao
John Lauriello
John M Kane
Juan Bustillo
P2860
P304
P356
10.1093/SCHBUL/SBU067
P407
P577
2014-05-27T00:00:00Z